Replies to post #732612 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

LP sure drives a hard bargain.  Eye rolls. 

>>NWBO will, as I suspect, get paid for licensing on condition of approval and did not, as you may have noticed, come to pass yet and is therefore not material yet.

[Investor082]

Does not make much sense to wait for approval on GBM indication when the big pharma will be licensing combo trial for other cancer indications.

I am fairly certain that there will be no significant upfront payment to NWBO and that NWBO will be required to fund this trial themselves. Yesterday, someone here pointed to similar trick NWBO deployed in 2017 for colorectal cancer combo trial. Never got off the ground because there was no funding support. This will be similar. Another carrot they have dangled to avoid retail selling on the UK approval spike.

Besides, if big funding was coming in the next month or two and LP was confident that it would result in a significant upside in share price why would she give the option of purchasing shares at .30 cents instead of just accepting higher interest rate loan during the last financing a week or two ago. To me, thats another sign!